Unlock Exclusive Insights: Comprehensive SDPA Summer Dermatology Conference 2025 Recap

To stay informed with the latest conference insights, subscribe to receive our eNewsletters.

Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect

The conference aimed at providing dermatology physician assistants with the latest in the specialty begins today in Washington, DC.

Inside SDPA Summer 2025: Dermatology Times Board Member Presenters

Join Dermatology Times at SDPA 2025 as our expert board members take the stage to share clinical insights, pearls, and practice-changing perspectives.

POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2025?

Click here to answer our poll and let us know what you're looking forward to at the SDPA's summer conference.

From Conference to Clinic: Eileen Cheever, MPAS, PA-C, Looks Ahead to Pearls Offered at SDPA Summer Meeting

Eileen Cheever, MPAS, PA-C, previews the SDPA Summer Dermatology Conference, calling it a can't-miss opportunity to learn, network, and reconnect.

DFD-29 Data Analysis Highlights Efficacy in Rosacea Regardless of Patient Differences in Body Weight

DFD-29 showed strong efficacy in rosacea regardless of body weight in 2 phase 3 trials, outperforming both placebo and doxycycline.

Addressing Cutaneous Squamous Cell Carcinoma Through Early Detection and Treatment

A poster at SDPA 2025 highlights the importance of early biopsy and genetic testing in aggressive cSCC, even in young patients without classic risk factors.

Day 1 Recap: SDPA Annual Summer Dermatology Conference 2025

Catch up on coverage from the first day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Overcoming Prior Authorizations: Janelle Ball Shares Strategies for Streamlining Dermatology Workflows

Janelle Ball of BC Educators offers actionable tips to boost prior authorization success and improve patient support in dermatology practices.

Emerging Insights into Apremilast’s Efficacy for Early Oligoarticular Psoriatic Arthritis Across BMI Spectrums

Apremilast improved joint symptoms and quality of life in patients with early oligoarticular PsA, with consistent efficacy across all BMI categories.

Chronic Hand Eczema or Something Else? Adam Friedman, MD, FAAD, Shares Diagnostic Tips for Differentiating

Adam Friedman, MD, FAAD, breaks down how to differentiate chronic hand eczema from similar conditions using history, morphology, and key clinical clues.

Dermatologic Evaluation Leads to Early Detection of Breast Cancer Metastasis

A poster at SDPA highlights that dermatologists play a vital role in early detection of metastatic breast cancer, with skin changes often serving as the initial clue of internal disease recurrence.

Orit Markowitz, MD, Explains How a Color Wheel Approach Can Sharpen Dermoscopic Decision-Making

Orit Markowitz, MD, shares how her color wheel method boosts diagnostic clarity in dermoscopy by simplifying how clinicians assess benign lesions.

Taking a Stepwise Approach to Managing Chronic Hand Eczema

Adam Friedman, MD, FAAD, outlines a stepwise approach to treating chronic hand eczema, from vehicle selection to systemic therapies and future innovations.

Long-Term Control of Generalized Pustular Psoriasis Achieved With Subcutaneous Spesolimab Following Severe Flare

Subcutaneous spesolimab maintained durable GPP control for 12 months after rapid clearance from IV spesolimab in a high-risk elderly patient.

Day 2 Recap: SDPA Annual Summer Dermatology Conference 2025

Catch up on coverage from the second day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Dupilumab Maintains Long-Term Flare Control Across Dosing Regimens in Atopic Dermatitis

A year-long study showed dupilumab alone effectively prevented flares in moderate to severe atopic dermatitis, with consistent safety across various dosing schedules.

Color as a Clinical Compass for Skin Cancer Detection

Orit Markowitz, MD, shares how a color-focused strategy helps spot early malignancies—even 2 mm lesions—across all skin tones.

Sustaining Repigmentation in Vitiligo Requires Gradual Step-Down Approach, Says Gina Mangin, PA-C

Ongoing maintenance therapy is essential to avoid relapse and preserve gains in repigmentation for patients with vitiligo, according to Gina Mangin, MPAS, PA-C.

Study Reports Low Incidence of Injection Site Reactions in Nemolizumab-Treated Patients

Nearly all injection site reactions among patients in the ARCADIA 1/2 and OLYMPIA 1/2 clinical trials were mild and transient in nature.

Amy Spizuoco, DO, FAOCD: Trichoscopy Improves Precision and Efficiency in Alopecia Diagnosis

Amy Spizuoco, DO, FAOCD, shared how trichoscopy enhances alopecia evaluation by improving diagnostic speed, accuracy, and reducing biopsy need.

Q&A: David Cotter, MD, PhD, Advancing Alopecia Areata Care With Systemic Therapies

David Cotter, MD, PhD, discusses diagnosing alopecia areata and selecting systemic treatments, including JAK inhibitors, from his SDPA 2025 presentation.

Roflumilast Foam 0.3% Demonstrates Favorable Pigmentation Profile in Seborrheic Dermatitis

A poster evaluating the STRATUM trial showed roflumilast foam 0.3% effectively treats seborrheic dermatitis with minimal pigment changes.

Day 3 Recap: SDPA Annual Summer Dermatology Conference 2025

Catch up on coverage from the third day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Maria Hordinsky, MD: Early Clue in Scarring Alopecia May Change Clinical Approach

Maria Hordinsky, MD, urges dermatology clinicians to consider allergic contact dermatitis when scarring alopecia treatments fail.

Clinical Pearls on JAK Inhibitor Utility and Research From Eileen Cheever, MPAS, PA-C

Eileen Cheever, MPAS, PA-C, highlights the growing role of JAK inhibitors in dermatology, including emerging data on prurigo nodularis and adolescent alopecia areata.

7-Year Safety Review Confirms Brodalumab’s Steady Risk Profile in US Postmarketing Surveillance

A poster from SDPA 2025 showed brodalumab maintains a consistent safety profile with no completed suicides and low infection rates.

What’s Shaping the Future of Alopecia Treatment, According to Today’s Clinicians

From JAK inhibitors to trichoscopy and contact allergy clues, experts at SDPA 2025 shared their top clinical pearls for managing alopecia and hair loss.

Dermatology Times' Weekly Crossword: SDPA Summer Edition

Test your knowledge of key words, terms, and pearls associated with this weekend's SDPA Annual Summer Dermatology Conference.

Top KOL Insights From SDPA Summer 2025

Expert our review of the top pearls, clinical strategies, and practice-changing tips from leading voices in dermatology at SDPA’s 2025 Summer Conference.

Day 4 Recap: SDPA Annual Summer Dermatology Conference 2025

Catch up on coverage from the fourth and final day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.